Cardiol Therapeutics (CRTPF) Stock Price, News & Analysis

Company Overview

Cardiol Therapeutics Inc. is a Canadian clinical-stage biotechnology company focused on developing anti-inflammatory therapies for diseases affecting the heart. The company’s research is centered on conditions in which inflammation can contribute to cardiac injury and impaired heart function, including myocarditis and pericarditis.

Cardiol’s lead investigational product, CardiolRx, is a pharmaceutical-grade oral cannabidiol formulation being evaluated as a potential treatment for acute myocarditis and recurrent pericarditis. The company has conducted clinical development programs, including the ARCHER study in acute myocarditis and the MAvERIC program in recurrent pericarditis. These products remain investigational and have not been established as approved treatments for these conditions.

Founded in 2017, Cardiol Therapeutics is headquartered in Toronto, Canada, and conducts its research and clinical development activities through studies in North America and other participating locations. The company is led by President and Chief Executive Officer David Elsley.

Key Stats

• Today's Range: $1.18 to $1.24
• 50-Day Range: $1.18 to $2.22
• 52-Week Range: $1.48 to $4.19
• Volume: 2.03 million shs
• Average Volume: 67,097 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: OTCMKTS:CRTPF
• CIK: N/A
• Web: www.cardiolrx.com
• Phone: (289) 910-0850
• Fax: N/A
• Employees: 20
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A